Literature DB >> 31812795

Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy.

Zengjun Fang1, Shaobin Pan2, Peng Gao2, Huagang Sheng2, Lingjun Li2, Lei Shi2, Yongqing Zhang2, Xiaoqing Cai3.   

Abstract

The stimuli-responsive charge-reversal nano drug delivery system (CRNDDS) for the treatment of tumors has attracted much attention as an effective drug delivery system. The charge-reversal nanocarriers are either uncharged or negatively charged under normal physiological environment; however, they acquire positive charged in tumor tissue microenvironment. The process of charge reversal from negative-to-positive results in not only quick drug release in acidic environment but also enhance the cellular uptake of drug through electrostatic absorptive endocytosis resulting in improvement of cancer therapeutic outcome. In this review, we discuss the recent advances in the study of charge-reversal nanocarriers that could control the distribution of drugs in response to specific stimuli, such as pH, reduced glutathione (GSH) concentration, enzyme concentration, light and thermal stimulation. The applications of CRNDDS in the tumor treatment was also analyzed and summarized.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Charge-reversal nano drug delivery systems; Stimuli-responsive; Targeted therapy; Tumor microenvironment

Year:  2019        PMID: 31812795     DOI: 10.1016/j.ijpharm.2019.118841

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis.

Authors:  Runan Zuo; Yan Zhang; Xiaorong Chen; Shiheng Hu; Xinhao Song; Xiuge Gao; Jiahao Gong; Hui Ji; Fengzhu Yang; Lin Peng; Kun Fang; Yingjun Lv; Junren Zhang; Shanxiang Jiang; Dawei Guo
Journal:  Int J Nanomedicine       Date:  2022-05-30

Review 2.  Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics.

Authors:  Lili Zhou; Manshu Zou; Yilin Xu; Peng Lin; Chang Lei; Xinhua Xia
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

Review 3.  Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors.

Authors:  Adviti Naik; Julie Decock
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

4.  Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells.

Authors:  Runan Zuo; Jingjing Zhang; Xinhao Song; Shiheng Hu; Xiuge Gao; Junqi Wang; Hui Ji; Chunlei Ji; Lin Peng; Hongbin Si; Gonghe Li; Kun Fang; Junren Zhang; Shanxiang Jiang; Dawei Guo
Journal:  Int J Nanomedicine       Date:  2021-02-26

5.  Cyclodextrin nanosponge for the GSH-mediated delivery of Resveratrol in human cancer cells.

Authors:  Marco Palminteri; Nilesh Kumar Dhakar; Alessandra Ferraresi; Fabrizio Caldera; Chiara Vidoni; Francesco Trotta; Ciro Isidoro
Journal:  Nanotheranostics       Date:  2021-01-21

Review 6.  The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery.

Authors:  Shaolong Qi; Xinyu Wang; Kun Chang; Wenbin Shen; Guocan Yu; Jianshi Du
Journal:  J Nanobiotechnology       Date:  2022-01-06       Impact factor: 10.435

Review 7.  Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.

Authors:  Ravi Raj Pal; Vasundhara Rajpal; Priya Singh; Shubhini A Saraf
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.